|
Thomas J. Newman, M.D. was appointed executive vice president late stage development in August 2006 and continues to serve as chief operating officer of PharmaNet, Inc., a subsidiary of PharmaNet Development Group. Before joining PharmaNet, Dr. Newman served as head of clinical research at Covance and head of drug safety at Bristol-Myers Squibb Corporation. | 